(2R,4S)-1-acetyl-N-hydroxy-4-(4-((2-methyl-5,6,7,8-tetrahydroquinolin-4-yl)methoxy)phenylsulfonyl)pyrrolidine-2-carboxamide

ID: ALA4097872

PubChem CID: 137659221

Max Phase: Preclinical

Molecular Formula: C24H29N3O6S

Molecular Weight: 487.58

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)N1C[C@@H](S(=O)(=O)c2ccc(OCc3cc(C)nc4c3CCCC4)cc2)C[C@@H]1C(=O)NO

Standard InChI:  InChI=1S/C24H29N3O6S/c1-15-11-17(21-5-3-4-6-22(21)25-15)14-33-18-7-9-19(10-8-18)34(31,32)20-12-23(24(29)26-30)27(13-20)16(2)28/h7-11,20,23,30H,3-6,12-14H2,1-2H3,(H,26,29)/t20-,23+/m0/s1

Standard InChI Key:  BRQTUHSEKFOXBN-NZQKXSOJSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   14.3682   -1.8419    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7850   -2.5586    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.1973   -1.8393    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0714   -2.9712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5005   -2.9754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4957   -3.8044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2105   -4.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9302   -3.8097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9306   -2.9774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2153   -2.5644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6437   -4.2241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6417   -5.0491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3552   -5.4634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3514   -6.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0641   -6.7035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7806   -6.2926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0667   -5.0527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7782   -5.4659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4879   -5.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4921   -4.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7805   -3.8231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0647   -4.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0616   -7.5285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3215   -2.6378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7704   -3.2507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1829   -3.9642    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9890   -3.7923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9497   -3.1649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6137   -2.4114    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4652   -3.8328    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6446   -3.7469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8479   -4.7183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0273   -4.8051    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3334   -5.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  2  1  6
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 18  1  0
 17 13  1  0
 17 18  2  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 15 23  1  0
  4 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27  4  1  0
 25 28  1  1
 28 29  2  0
 28 30  1  0
 30 31  1  0
 26 32  1  0
 32 33  2  0
 32 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4097872

    ---

Associated Targets(Human)

ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.58Molecular Weight (Monoisotopic): 487.1777AlogP: 2.12#Rotatable Bonds: 6
Polar Surface Area: 125.90Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.72CX Basic pKa: 6.55CX LogP: 1.00CX LogD: 0.92
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.47Np Likeness Score: -0.81

References

1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF..  (2017)  Identification of novel TACE inhibitors compatible with topical application.,  27  (8): [PMID:28274635] [10.1016/j.bmcl.2017.02.035]

Source